JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

JNJ

238.23

-0.2%↓

UNH

273.19

-0.82%↓

TMO

539.43

-1.35%↓

ABT

112.32

+1.08%↑

ISRG

495.1

+0.46%↑

Strona główna・Stock List・Geron Corp

Geron Corp

Closed

SectorHealthcare

1.62 1.25

Buy Sell

Overview

Share price change

24h

Current

Min

1.58

Max

1.63

Key metrics
By Trading Economics
Income	-2.1M -18M
Sales	-1.8M 47M
EPS	-0.03
Profit margin	-39.02
Employees	229
EBITDA	-2.1M -9.7M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+148.45% upside

Dividends
By Dow Jones
Next Earnings	25 lut 2026

Market Stats
By TradingEconomics
Market Cap	217M 983M
Previous open	0.37
Previous close	1.62

News Sentiment

By Acuity

67%

33%

302 / 352 Ranking in Healthcare

Geron Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 lut 2026, 23:26 UTC

Major Market Movers

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

10 lut 2026, 22:31 UTC

Earnings

Correction to America Movil 4Q Profit Article

10 lut 2026, 22:22 UTC

Earnings

America Movil 4Q Profit Jumps on Lower Financial Costs

10 lut 2026, 23:51 UTC

Market Talk

Earnings

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

10 lut 2026, 23:42 UTC

Market Talk

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

10 lut 2026, 23:40 UTC

Market Talk

Earnings

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

10 lut 2026, 23:21 UTC

Market Talk

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

10 lut 2026, 23:21 UTC

Market Talk

Global Equities Roundup: Market Talk

10 lut 2026, 22:17 UTC

Market Talk

Australia's One Nation Now Commands Working Class Vote -- Market Talk

10 lut 2026, 22:15 UTC

Earnings

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

10 lut 2026, 22:10 UTC

Earnings

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

10 lut 2026, 22:10 UTC

Earnings

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

10 lut 2026, 22:09 UTC

Earnings

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

10 lut 2026, 22:09 UTC

Earnings

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

10 lut 2026, 22:01 UTC

Earnings

Intact Financial 4Q EPS C$5.24 >IFC.T

10 lut 2026, 21:54 UTC

Earnings

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

10 lut 2026, 21:53 UTC

Earnings

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

10 lut 2026, 21:51 UTC

Earnings

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

10 lut 2026, 21:51 UTC

Earnings

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 lut 2026, 21:51 UTC

Earnings

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

10 lut 2026, 21:51 UTC

Earnings

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

10 lut 2026, 21:51 UTC

Earnings

Acquisitions, Mergers, Takeovers

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

10 lut 2026, 21:50 UTC

Earnings

Acquisitions, Mergers, Takeovers

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

10 lut 2026, 21:50 UTC

Earnings

James Hardie Industries 3Q EPS 12c >JHX

10 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 lut 2026, 21:50 UTC

Earnings

James Hardie Industries 3Q Adj EPS 24c >JHX

10 lut 2026, 21:49 UTC

Earnings

James Hardie Industries 3Q Sales $1.24B >JHX

10 lut 2026, 21:49 UTC

Earnings

Acquisitions, Mergers, Takeovers

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

10 lut 2026, 21:48 UTC

Earnings

Acquisitions, Mergers, Takeovers

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

10 lut 2026, 21:47 UTC

Earnings

Acquisitions, Mergers, Takeovers

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Peer Comparison

Price change

Geron Corp Forecast

Price Target

By TipRanks

148.45% upside

12 Months Forecast

Average 4 USD 148.45%

High 5 USD

Low 3 USD

Based on 4 Wall Street analysts offering 12 month price targets forGeron Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

Buy

Hold

Sell

Based on 4 analysts giving stock ratings to Geron Corp - Dist in the past 3 months.

Sentiment

By Acuity

302 / 352 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.